| Study Protocol Number | Study Title and Description |
|---|---|
| 26-0676 |
A Multicentre, Parallel-group, Phase II, Randomised,
Double-blind, 4 Arm Study to Evaluate Efficacy and Safety of
AZD1163 in Participants with Moderately-to-Severely Active
Rheumatoid Arthritis (LaunchPAD-RA)
Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163 |
| 25-0039 |
A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Idiopathic Inflammatory Myopathy or Active Juvenile Idiopathic Inflammatory Myopathy
This is a Phase 1/2, open-label study designed to evaluate the safety and efficacy of CABA-201 in patients with active IIM or JIIM and to identify an appropriate dose for future studies. |
| 24-2239 |
Study to Test How Safe and Effective IMVT-1402 is in Adults with Active Subacute Cutaneous Lupus Erythematosus
Researchers are testing a drug called IMVT-1402 to see if it is safe and if it helps people with skin lupus (a type called subacute or chronic cutaneous lupus) with or without lupus that affects the whole body. |
| 24-2207 |
Studying the Long-term Safety & Effectiveness of Avacopan in People with ANCA-associated Vasculitis
This study wants to see if avacopan is safe and works well for people with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. We also want to find out if it helps prevent the disease from coming back. |
| 24-1080 |
StopRA : National Study to Better Understand the Development of Rheumatoid Arthritis in At-Risk People
We are looking for adults to join a national study to help us learn more about how rheumatoid arthritis (RA) develops. |
| 23-0022 |
Better Understanding of Joint Destruction in People with Rheumatoid Arthritis
This study wants to find better treatments for people with autoimmune diseases like rheumatoid arthritis (RA). By studying the different types of cells found in people with RA, researchers can learn more about how RA damages joints. |
| 25-0875 |
Exploring Anifrolumab as a Treatment Option for People with Polymyositis and Dermatomyositis
In this study, we want to learn whether adding anifrolumab to standard treatment for people with polymyositis (PM) and dermatomyositis (DM) works better than standard treatment alone. We also want to learn more about how PM and DM affect the body. |
| 25-1323 |
Exploring Cell Therapy for People Living with Autoimmune Diseases
Researchers are studying whether a treatment called ALLO329 CAR T cells is safe and works well for adults with autoimmune disease such as systemic lupus erythematosus (SLE), idiopathic inflammatory myopathy (IIM), and systemic sclerosis (SSc). |
| 17-0977 |
Study Exploring How Spondyloarthritis Develops Among First Degree Relatives
This study wants to learn more about spondyloarthritis, a type of arthritis that causes a lot of inflammation. We are looking for adults who have a parent, sibling, or child who has spondyloarthritis or a similar health problem to join our study. |
| 24-1932 |
Study to Test the Efficacy and Safety of Anifrolumab in Adults with Chronic CLE
This study is testing a new injectable medication called anifrolumab to see how safe and effective it is for adults with chronic cutaneous lupus erythematosus (CLE). Our goal is to find better treatments for people living with CLE. |
| 24-0657 |
Safety and Efficacy of Benralizumab in Children with EGPA
In this study we want to learn more about the effects of the study drug, benralizumab, for treating children with eosinophilic granulomatosis with polyangiitis (EGPA). |